XML 64 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisitions - Additional Information (Details)
$ in Thousands
 36 Months Ended
Sep. 09, 2020
USD ($)
Sep. 08, 2020
USD ($)
Apr. 01, 2020
USD ($)
Jul. 23, 2019
USD ($)
Dec. 31, 2021
Number
Business Acquisition [Line Items]          
Number of acquisitions | Number         4
Number of businesses acquired | Number         2
Taurus Acquisition [Member]          
Business Acquisition [Line Items]          
Percentage share of post clinical acquire product revenues 25.00%        
Business combination consideration transferred $ 5,200        
Payments to acquire businesses gross 4,600        
Business combination consideration transferred liabilities incurred 500        
Business combination consideration transferred earnout rights 4,500        
Taurus Acquisition [Member] | Research and Development Expense [Member]          
Business Acquisition [Line Items]          
Business combination consideration transferred earnout rights $ 25,000        
xCella Acquisition [Member]          
Business Acquisition [Line Items]          
Percentage share of future milestone payments   25.00%      
Business combination consideration transferred   $ 7,100      
Business combination consideration transferred liabilities incurred   500      
Business combination consideration transferred earnout rights   5,000      
xCella Acquisition [Member] | Research and Development Expense [Member]          
Business Acquisition [Line Items]          
Business combination consideration transferred earnout rights   $ 25,750      
Icagen Acquisition [Member]          
Business Acquisition [Line Items]          
Acquired finite lived intangible assets weighted average useful life     9 years 8 months 12 days    
Business combination consideration transferred     $ 19,900    
Payments to acquire businesses gross     15,100    
Business combination contingent consideration revenue milestone payment     $ 4,800    
Business combination cash flow discounted rate     17.00%    
Ab Initio Acquisition [Member]          
Business Acquisition [Line Items]          
Business combination consideration transferred       $ 12,000  
Payments to acquire businesses gross       $ 11,900  
Business combination cash flow discounted rate       12.00%  
Business combination consideration transferred to holdback for potential indemnification claims       $ 150  
Technology-Based Intangible Assets [Member] | Taurus Acquisition [Member]          
Business Acquisition [Line Items]          
Acquired finite lived intangible assets weighted average useful life 10 years        
Technology-Based Intangible Assets [Member] | xCella Acquisition [Member]          
Business Acquisition [Line Items]          
Acquired finite lived intangible assets weighted average useful life   15 years      
Technology-Based Intangible Assets [Member] | Icagen Acquisition [Member]          
Business Acquisition [Line Items]          
Acquired finite lived intangible assets weighted average useful life     10 years    
Finite lived intangible assets acquired     $ 1,700    
Technology-Based Intangible Assets [Member] | Ab Initio Acquisition [Member]          
Business Acquisition [Line Items]          
Acquired finite lived intangible assets weighted average useful life       20 years  
Customer Relationships [Member] | Icagen Acquisition [Member]          
Business Acquisition [Line Items]          
Acquired finite lived intangible assets weighted average useful life     9 years 7 months 6 days    
Finite lived intangible assets acquired     $ 11,100    
Earnout Rights [Member] | Icagen Acquisition [Member]          
Business Acquisition [Line Items]          
Business combination contingent consideration arrangements range of outcomes value high     $ 25,000